Andrew Geall

Andrew Geall

Company: Replicate Bioscience

Job title: Co-founder & Chief Development Officer

Seminars:

Panel Discussion: Increasing Collaboration Between Functions Such as Discovery, Formulation, Optimization & CMC to Accelerate Entry into Clinic 3:15 pm

The successful development of a non-viral delivery system needs an immense amount of cross-functional collaboration between not just chemistry and biology focused teams, but also between functions such as discovery, formulation, process development, and CMC. Hence, it is important to develop a robust strategy to integrate various teams and increase collaborations. This panel will delve…Read more

day: Conference Day Two

Panel Discussion: Discussing the Future of Non-Viral Delivery of RNA & Emerging Systems of Delivery Beyond LNPs 11:15 am

Join us for a thought-provoking panel discussion as experts delve into the future of non-viral delivery whilst exploring emerging systems of delivery beyond lipid nanoparticles (LNPs). Gain valuable insights and stay ahead in the rapidly evolving field of drug delivery. What are the ground-breaking advancements in non-viral delivery systems that are opening new frontiers for…Read more

day: Conference Day Two

Utilizing Recent Innovations in Non-Viral Delivery of RNA With LNPs, Polymers & Antibodies to Inform the Development of Your Own Delivery System 9:00 am

Examining LNP delivery of 2nd generation self-replicating RNA to upgrade your LNP platform Developing your own polymers with a look at polymer delivery of 1st generation self-replicating RNA Determining future directions for nanoparticle delivery using lessons learned from antibody siRNA conjugatesRead more

day: Conference Day Two

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.